Connextions / Optum / UnitedHealth Group Company Profile

14:06 EDT 21st September 2018 | BioPortfolio

News Articles [747 Associated News Articles listed on BioPortfolio]

Buying Binge For UnitedHealth's Optum Is Only Just Beginning

UnitedHealth Group’s Optum is signaling more acquisitions of medical providers lie ahead after UnitedHealth CEO Dave Wichman said executives will be "strong deployers of capital."

Buoyed By Optum, UnitedHealth Group Remains On A Roll

UnitedHealth Group's profits soared 31% to $2.8 billion in the first quarter thanks to solid performance across insurance and its Optum health services lines of business.

Anchored By Optum's Reach, UnitedHealth's Profits Jump

UnitedHealth Group's profits jumped 28% in the second quarter on increased sales of both health plans and a menu of Optum health services including pharmacy benefit management, surgical and outpatient...

UnitedHealth names former GSK CEO Andrew Witty as Optum head

(Reuters) - Health insurer UnitedHealth Group Inc on Tuesday named its board member and former GlaxoSmithKline Plc head Andrew Witty as chief executive of its pharmacy benefit unit, Optum, effective J...

UnitedHealth's Optum And Humana In Blockchain Deal To Improve Doctor Directories

Health insurers UnitedHealth Group and Humana will apply blockchain technology to improve inaccurate doctor directories as part of a new partnership that also includes Quest Diagnostics, Optum and Mul...

UnitedHealth Taps Former GlaxoSmithKline Exec to Lead Optum

Heather LandiUnitedHealth Group, based in Minneapolis, has named Andrew Witty, the former CEO of GlaxoSmithKline, as the new chief executive of Optum, the insurance company’s health services and tec...

UnitedHealth Group Schedules Third Quarter Earnings Release and Conference Call for October 16, 2018

UnitedHealth Group (NYSE: UNH) will release its third quarter 2018 financial results on Tuesday, October 16, 2018, before the market opens, and will host a teleconference at 8:45 ...

UnitedHealth Group Schedules Second Quarter Earnings Release and Conference Call for July 17, 2018

UnitedHealth Group (NYSE: UNH) will release its second quarter 2018 financial results on Tuesday, July 17, 2018, before the market opens, and will host a teleconference at 8:45 a....

PubMed Articles [1721 Associated PubMed Articles listed on BioPortfolio]

Group Influences on Engaging Self-Control: Children Delay Gratification and Value It More When Their In-Group Delays and Their Out-Group Doesn't.

Self-control emerges in a rich sociocultural context. Do group norms around self-control influence the degree to which children use it? We tested this possibility by assigning 3- to 5-year-old childre...

Does Timing of Surgery Affect Treatment of the Terrible Triad of the Elbow?

BACKGROUND This study investigated the influence of surgical timing on the treatment of terrible triad of the elbow (TTE). MATERIAL AND METHODS After exclusion, 63 patients were enrolled in this study...

An Examination of Group Size and Valence in Delay Discounting of Shared Outcomes.

Previous research has examined delay discounting in a group context, where the outcomes are shared with others. These studies indicate shallow delay discounting in a group context compared to an indiv...

Ameliorating effects of tempol on methotrexate-induced liver injury in rats.

Methotrexate (MTX) is used in the treatment of certain types of cancers and chronic inflammatory illnesses, although the clinical use of MTX is limited due to its adverse effects, the most common of w...

Medulloblastoma with transitional features between Group 3 and Group 4 is associated with good prognosis.

Medulloblastoma, the most common malignant pediatric brain tumor, is a heterogeneous disease, with the existence of at least four molecular types: Wingless (WNT), Sonic Hedgehog (SHH), Group 3 and Gro...

Clinical Trials [3921 Associated Clinical Trials listed on BioPortfolio]

Real World Glycemic Effectiveness of Linagliptin

A non-interventional cohort study using existing data from patients in the Optum Clinical Database which contains electronic health record (EHR) data from providers across the United State...

Comparison of the Effectiveness and Tolerability of Exenatide Once-weekly Compared to Basal Insulins

Exenatide once weekly (Bydureon) was approved in January 2012 by FDA in USA for the treatment of type 2 diabetes mellitus. Evidence from clinical trials suggested that Bydureon improves gl...

Chronic Obstructive Pulmonary Disease (COPD) Dual Therapy Burden of Illness

The main purpose of the study is to assess the burden of illness for, COPD using both patient-reported symptom burden and claims-based economic burden, among the subjects treated with sing...

The Influence of Hypotensive Drugs on Mineral Status in Experimental and Clinical Studies

The aim of the study was to evaluate the effects of hypotensive treatment combined with a higher zinc supply in the diet and supplements on the mineral status and selected biochemical para...

Safety, Tolerability and Pharmacokinetics of Escalating Single Doses of TAK-828 in Healthy Participants

The purpose of this study is to evaluate the safety and tolerability of single oral doses of TAK-828 in healthy non-Japanese and Japanese participants.

Companies [1660 Associated Companies listed on BioPortfolio]

Connextions / Optum / UnitedHealth Group

Optum and QSSI, Inc.

Optum is a leading information and technology-enabled health services business dedicated to helping make the health system work better for everyone. With more than 50,000 people w...

Optum / UnitedHealth Group

UnitedHealth Group

UnitedHealth Group is a diversified health and well-being company dedicated to making health care work better. Headquartered in Minneapolis, Minn., UnitedHealth Group offers a bro...

Optum Jeffrey Smith Optum (773)

Optum ( is a leading information and technology-enabled health services business dedicated to helping make the health system work better for everyone. Optum c...

More Information about "Connextions / Optum / UnitedHealth Group" on BioPortfolio

We have published hundreds of Connextions / Optum / UnitedHealth Group news stories on BioPortfolio along with dozens of Connextions / Optum / UnitedHealth Group Clinical Trials and PubMed Articles about Connextions / Optum / UnitedHealth Group for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Connextions / Optum / UnitedHealth Group Companies in our database. You can also find out about relevant Connextions / Optum / UnitedHealth Group Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record